INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Enterprise Value: 11.07M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 11.07M |
| May 02, 2024 | 11.09M |
| May 01, 2024 | 11.27M |
| April 30, 2024 | 11.27M |
| April 29, 2024 | 11.44M |
| April 26, 2024 | 11.22M |
| April 25, 2024 | 11.22M |
| April 24, 2024 | 11.74M |
| April 23, 2024 | 12.10M |
| April 22, 2024 | 11.93M |
| April 19, 2024 | 12.29M |
| April 18, 2024 | 12.70M |
| April 17, 2024 | 13.52M |
| April 16, 2024 | 10.62M |
| April 15, 2024 | 10.54M |
| April 12, 2024 | 10.67M |
| April 11, 2024 | 10.99M |
| April 10, 2024 | 10.60M |
| April 09, 2024 | 10.70M |
| April 08, 2024 | 10.78M |
| April 05, 2024 | 10.77M |
| April 04, 2024 | 10.81M |
| April 03, 2024 | 10.94M |
| April 02, 2024 | 10.94M |
| April 01, 2024 | 11.18M |
| Date | Value |
|---|---|
| March 28, 2024 | 11.49M |
| March 27, 2024 | 11.41M |
| March 26, 2024 | 11.05M |
| March 25, 2024 | 11.37M |
| March 22, 2024 | 11.35M |
| March 21, 2024 | 11.27M |
| March 20, 2024 | 11.17M |
| March 19, 2024 | 11.07M |
| March 18, 2024 | 11.07M |
| March 15, 2024 | 11.10M |
| March 14, 2024 | 11.22M |
| March 13, 2024 | 11.17M |
| March 12, 2024 | 11.25M |
| March 11, 2024 | 11.32M |
| March 08, 2024 | 11.55M |
| March 07, 2024 | 11.35M |
| March 06, 2024 | 11.42M |
| March 05, 2024 | 11.45M |
| March 04, 2024 | 11.67M |
| March 01, 2024 | 11.55M |
| February 29, 2024 | 11.40M |
| February 28, 2024 | 11.25M |
| February 27, 2024 | 11.40M |
| February 26, 2024 | 11.37M |
| February 23, 2024 | 11.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.149M
Minimum
Jun 21 2023
81.21M
Maximum
Mar 09 2021
24.02M
Average
27.66M
Median
Apr 13 2020
Enterprise Value Benchmarks
| Abbott Laboratories | 191.38B |
| Perspective Therapeutics Inc | 1.055B |
| Xtant Medical Holdings Inc | 126.76M |
| Asensus Surgical Inc | 44.48M |
| Catheter Precision Inc | 0.8601M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.995M |
| Revenue (Quarterly) | 1.382M |
| Total Expenses (Quarterly) | 2.890M |
| EPS Diluted (Quarterly) | -0.8003 |
| Gross Profit Margin (Quarterly) | 35.82% |
| Profit Margin (Quarterly) | -144.4% |
| Earnings Yield | -925.5% |
| Normalized Earnings Yield | -916.81 |